Page last updated: 2024-10-30

beta-lapachone and Autosomal Dominant Striatonigral Degeneration

beta-lapachone has been researched along with Autosomal Dominant Striatonigral Degeneration in 1 studies

beta-lapachone: antineoplastic inhibitor of reverse transcriptase, DNA topoisomerase, and DNA polymerase
beta-lapachone : A benzochromenone that is 3,4-dihydro-2H-benzo[h]chromene-5,6-dione substituted by geminal methyl groups at position 2. Isolated from Tabebuia avellanedae, it exhibits antineoplastic and anti-inflammatory activities.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lai, TS1
Liu, Y1
Tucker, T1
Daniel, KR1
Sane, DC1
Toone, E1
Burke, JR1
Strittmatter, WJ1
Greenberg, CS1

Other Studies

1 other study available for beta-lapachone and Autosomal Dominant Striatonigral Degeneration

ArticleYear
Identification of chemical inhibitors to human tissue transglutaminase by screening existing drug libraries.
    Chemistry & biology, 2008, Sep-22, Volume: 15, Issue:9

    Topics: Animals; Calcium; Combinatorial Chemistry Techniques; Disease Models, Animal; Drosophila melanogaste

2008
chemdatabank.com